Search

everythinglearnresearchcommunity

for

Search:↓

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Large language models often give biased or inaccurate medical responses, especially for LGBTQIA+ prompts.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

More severe alopecia areata can lower quality of life.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

Medical questionnaires could modernize healthcare by improving access and efficiency but need guidelines to ensure quality care.

Medicalization has shaped how society views health and gender roles over the past 200 years.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

People often have negative attitudes toward those with alopecia, especially if it's severe or seen as a medical issue.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.